SkinHealth Systems Inc.
SkinHealth Systems Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 206 | 204 | 233 | 219 | 212 | 373 | 370 | 359 | 350 | 445 | 523 | 559 | |||||
Accounts Receivable Net Current | 18 | 19 | 22 | 22 | 25 | 23 | 28 | 36 | 41 | 48 | 55 | 67 | |||||
Inventory Net | 47 | 48 | 48 | 56 | 59 | 66 | 69 | 73 | 77 | 96 | 91 | 75 | |||||
Income Taxes Receivable | 2 | 2 | 2 | 3 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | |||||
Prepaid Expense And Other Assets Current | 23 | 5 | 5 | 7 | 8 | 7 | 9 | 16 | 21 | 26 | 29 | 36 | |||||
Assets Current | 295 | 278 | 310 | 308 | 306 | 469 | 477 | 485 | 490 | 615 | 698 | 738 | |||||
Property Plant And Equipment And Finance Lease Rig… | - | 2 | 3 | 3 | 4 | 4 | 6 | 8 | 10 | 12 | 14 | 16 | |||||
Operating Lease Right Of Use Asset | 19 | 20 | 12 | 14 | 12 | 12 | 14 | 15 | 15 | 16 | 12 | 13 | |||||
Finite Lived Intangible Assets Net | 30 | 33 | 36 | 38 | 43 | 46 | 48 | 51 | 54 | 58 | 62 | 65 | |||||
Goodwill | 126 | 126 | 127 | 126 | 126 | 124 | 123 | 125 | 125 | 125 | 126 | 125 | |||||
Deferred Income Tax Assets Net | 2 | 2 | 2 | 1 | 3 | 4 | 4 | 1 | 3 | 2 | 1 | 1 | |||||
Other Assets Noncurrent | 11 | 11 | 12 | 13 | 13 | 14 | 14 | 15 | 16 | 16 | 16 | 16 | |||||
Assets | 487 | 473 | 500 | 504 | 508 | 674 | 686 | 700 | 712 | 845 | 929 | 973 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Convertible Debt Current | 103 | 103 | 124 | - | - | - | 0 | - | - | - | - | - | |||||
Accounts Payable Current | 16 | 16 | 16 | 17 | 23 | 23 | 22 | 23 | 27 | 37 | 45 | 36 | |||||
Employee Related Liabilities Current | 13 | 13 | 25 | 19 | 15 | 15 | 18 | 17 | 17 | 15 | 22 | 21 | |||||
Operating Lease Liability Current | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | |||||
Accrued Income Taxes Current | 0 | 0 | 1 | 1 | 3 | 3 | 3 | 1 | 2 | 3 | 3 | 2 | |||||
Accrued Liabilities Current | 32 | 19 | 15 | 19 | 14 | 17 | 20 | 28 | 24 | 24 | 20 | 30 | |||||
Liabilities Current | 168 | 155 | 186 | 62 | 59 | 63 | 68 | 74 | 75 | 94 | 115 | 126 | |||||
Operating Lease Liability Noncurrent | 18 | 19 | 9 | 11 | 8 | 10 | 11 | 12 | 13 | 14 | 9 | 10 | |||||
Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | |||||
Warrants And Rights Outstanding | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 5 | 4 | 7 | |||||
Convertible Debt Noncurrent | 242 | 241 | 240 | 363 | 363 | 553 | 552 | 551 | 551 | 665 | 738 | 737 | |||||
Other Liabilities Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 0 | |||||
Liabilities | 431 | 418 | 439 | 438 | 434 | 628 | 634 | 640 | 643 | 781 | 870 | 883 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 584 | 581 | 580 | 577 | 575 | 570 | 567 | 561 | 553 | 547 | 541 | 565 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -2 | -1 | -2 | -2 | -6 | -7 | -4 | -5 | -4 | -3 | -5 | |||||
Retained Earnings Accumulated Deficit | -527 | -524 | -517 | -509 | -498 | -518 | -508 | -498 | -479 | -480 | -479 | -469 | |||||
Stockholders Equity | 56 | 55 | 61 | 66 | 74 | 46 | 52 | 60 | 69 | 63 | 59 | 90 | |||||
Liabilities And Stockholders Equity | 487 | 473 | 500 | 504 | 508 | 674 | 686 | 700 | 712 | 845 | 929 | 973 | |||||
Allowance For Doubtful Accounts Receivable Current | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 8 | 7 | 7 | 5 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 320 | 320 | 320 | 320 | 320 | 320 | 320 | 320 | 320 | 320 | 320 | 320 | |||||
Common Stock Shares Issued | 130 | 129 | 128 | 127 | 127 | 125 | 125 | 124 | 124 | 123 | 123 | 133 | |||||
Shares Outstanding | 130 | 129 | 128 | 127 | 127 | 125 | 125 | 124 | 124 | 123 | 123 | 133 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.95% | -27.47% | -19.56% | - | - | - | - | - | - | - | - | - |
| 2025 | 31.45% | 57.26% | 44.35% | 30.82% | 23.90% | -12.58% | 14.73% | 13.18% | 18.60% | -14.62% | -18.58% | -26.98% |
| 2024 | -38.44% | -46.52% | -50.14% | 38.76% | 6.98% | 27.91% | -11.76% | -2.94% | -1.76% | -15.49% | -19.72% | 14.79% |
| 2023 | - | - | - | -13.90% | -15.45% | -36.24% | 117.27% | 98.56% | 114.39% | 3.34% | -6.41% | -38.44% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.76 | 1.79 | 1.66 | 4.98 | 5.15 | 7.47 | 7.00 | 6.56 | 6.49 | 6.57 | 6.07 | 5.86 | |||||
| Quick Ratio | 1.34 | 1.45 | 1.37 | 3.95 | 4.02 | 6.31 | 5.85 | 5.35 | 5.19 | 5.27 | 5.03 | 4.98 | |||||
| Working Capital | 127.04M | 122.49M | 123.24M | 246.46M | 246.67M | 406.57M | 408.97M | 411.10M | 414.20M | 521.26M | 583.24M | 612.13M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 7.76 | 7.57 | 7.19 | 6.67 | 5.86 | 13.63 | 12.24 | 10.71 | 9.29 | 12.35 | 14.64 | 9.82 | |||||
| Interest Coverage TTM | -0.17 | -0.46 | -1.08 | -1.82 | -3.75 | -6.36 | -6.51 | -6.98 | -11.36 | -9.85 | -9.59 | -8.40 | |||||
| Debt Ratio | 0.89 | 0.88 | 0.88 | 0.87 | 0.85 | 0.93 | 0.92 | 0.91 | 0.90 | 0.93 | 0.94 | 0.91 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.58 | 0.52 | 0.51 | 0.50 | 0.51 | 0.42 | 0.41 | 0.42 | 0.43 | 0.43 | 0.41 | 0.38 | |||||
| Days Sales Outstanding TTM | 26.86 | 25.81 | 29.96 | 35.35 | 39.11 | 40.14 | 44.95 | 54.12 | 57.83 | 54.99 | 60.16 | 68.92 | |||||
| Receivables Turnover TTM | 13.59 | 14.14 | 12.18 | 10.32 | 9.33 | 9.09 | 8.12 | 6.74 | 6.31 | 6.64 | 6.07 | 5.30 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.22 | -0.05 | -0.07 | -0.09 | -0.14 | -0.31 | -0.20 | -0.23 | -0.59 | -0.56 | -0.76 | -0.63 | |||||
| Free Cash Flow Per Share TTM | 0.23 | 0.22 | 0.29 | 0.28 | 0.29 | 0.28 | 0.12 | -0.05 | 0.01 | 0.13 | 0.14 | 0.13 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 66.35% | 64.91% | 65.28% | 64.81% | 61.50% | 56.60% | 54.53% | 50.53% | 33.43% | 38.00% | 38.97% | 44.06% | |||||
| Operating Profit Margin TTM | -1.49% | -3.57% | -6.92% | -9.31% | -14.00% | -19.48% | -20.27% | -22.72% | -38.11% | -33.22% | -32.89% | -28.80% | |||||
| Net Profit Margin TTM | -9.80% | -2.04% | -3.16% | -3.89% | -6.13% | -11.94% | -8.70% | -8.10% | -22.85% | -20.49% | -25.16% | -21.08% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -6.46% | -8.17% | -10.02% | -13.15% | -15.34% | -17.97% | -16.00% | -12.94% | -6.26% | 4.35% | 8.78% | 15.53% | |||||
| Net Income Growth (1Y) | 49.61% | -84.28% | -67.29% | -58.31% | -77.29% | -52.18% | -70.94% | -66.53% | 701.47% | 975.25% | -326.38% | -513.05% | |||||
| EPS Growth (1Y) | 45.54% | -84.62% | -67.95% | -59.24% | -77.72% | -52.93% | -69.09% | -64.15% | 759.76% | 1,056.47% | -353.67% | -568.66% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -3.16 | -18.79 | -18.45 | -21.50 | -12.67 | -4.35 | -6.77 | -6.34 | -2.84 | -6.79 | -4.09 | -9.50 | |||||
| P/B TTM | 1.62 | 2.06 | 2.88 | 3.85 | 3.25 | 3.64 | 3.80 | 2.99 | 3.43 | 8.64 | 6.90 | 8.89 | |||||
| P/S TTM | 0.31 | 0.38 | 0.58 | 0.84 | 0.78 | 0.52 | 0.59 | 0.51 | 0.65 | 1.39 | 1.03 | 2.00 | |||||
| Market Cap | 89.81M | 113.74M | 175.67M | 252.51M | 240.80M | 167.61M | 196.89M | 178.64M | 237.54M | 546.65M | 409.53M | 800.04M | |||||
| Enterprise Value | 228.95M | 253.60M | 307.38M | 396.50M | 391.89M | 347.56M | 379.02M | 371.16M | 438.62M | 767.51M | 624.87M | 977.91M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 29.87M | 28.45M | 37.18M | 35.57M | 36.26M | 35.53M | 15.38M | -6.22M | 1.26M | 16.06M | 17.93M | 16.76M | |||||
| Net Debt | 139.14M | 139.86M | 131.72M | 143.99M | 151.10M | 179.95M | 182.14M | 192.52M | 201.08M | 220.85M | 215.35M | 177.87M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
SkinHealth Systems Inc. (SKIN) — SEC Financial Statements & Analysis
SkinHealth Systems Inc. (SKIN) is a surgical & medical instruments & apparatus company, incorporated in DE. SkinHealth Systems Inc. trades on Nasdaq as: SKIN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SkinHealth Systems Inc. reported a -6.46% year-over-year revenue growth, a Gross Profit Margin of 66.35% (TTM), a Debt-to-Equity ratio of 7.76x, a Price-to-Sales (P/S) ratio of 0.31x (TTM), a Price-to-Book (P/B) ratio of 1.62x (TTM), at a market cap of $89.81M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -6.46%
- Gross Profit Margin TTM
- 66.35%
- Debt To Equity
- 7.76x
- P/S TTM
- 0.31x
- P/B TTM
- 1.62x
- Market Cap
- $89.81M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SkinHealth Systems Inc. in?
SkinHealth Systems Inc. (SKIN) operates in the Surgical & Medical Instruments & Apparatus industry.
What is SKIN's market cap?
SkinHealth Systems Inc. (SKIN) has a market capitalization of $89.81M as of 2026-06-30.
What exchange does SKIN trade on?
SkinHealth Systems Inc. (SKIN) trades on the Nasdaq.
Where is SkinHealth Systems Inc. incorporated?
SkinHealth Systems Inc. is incorporated in DE.